ENDONOVO THERAPEUTICS, INC. (ENDV) › Total LiabilitiesENDONOVO THERAPEUTICS, INC. (ENDV) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $1.44M2012: $1.96M2013: $4.21M2014: $4.74M2015: $9.69M2016: $8.88M2017: $14.16M2018: $15.63M2019: $23.78M2020: $16.98M2021: $17.78M2022: $33.46M$33.46M2011Total Liabilities (USD)2022Fiscal YearTotal LiabilitiesChange YoY2022$33.46M+88.2%2021$17.78M+4.7%2020$16.98M-28.6%2019$23.78M+52.1%2018$15.63M+10.4%2017$14.16M+59.5%2016$8.88M-8.3%2015$9.69M+104.4%2014$4.74M+12.7%2013$4.21M+114.7%2012$1.96M+36.0%2011$1.44M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share